Fondared 2.5mg Injection (Fondaparinux 2.5mg)

Fondared 2.5mg Injection

FondaRed 2.5 Injection is used to prevent the formation and growth of blood clots that may potentially form during certain surgical procedures and in patients with certain specific medical conditions like acute coronary syndrome (sudden or reduced blood flow to the heart) with or without ST-segment elevation or unstable angina. It also helps in preventing the formation of blood clots in catheters that are placed in veins for a prolonged period of time. This medicine is not recommended for use in children.

Side effects

Major & minor side effects for FondaRed 2.5 Injection
Pale skin
Trouble breathing
Unusual bleeding or bruising
Unusual tiredness or weakness
Fever
Nausea or Vomiting
Bleeding gums
Dizziness
Sore throat
Dry mouth

Uses of FondaRed 2.5 Injection

What is it prescribed for?
Deep Vein Thrombosis Prophylaxis and Treatment after surgery
This medicine is used to treat and prevent the formation of blood clots in veins following hip fracture, hip replacement, knee replacement surgery, abdominal surgery, etc.
Deep Vein Thrombosis
This medicine is used for the prevention and treatment of blood clot formation in a deep vein, most commonly in the legs.
Pulmonary Embolism
This medicine is used for the treatment and prevention of pulmonary embolism, a condition where one or more arteries in the lungs become blocked by a clot. The blood clot is normally formed elsewhere and migrates to the lung via blood.
Acute Coronary Syndrome
This medicine is used for the treatment of acute coronary syndrome (sudden or reduce blood flow to the heart) with or without ST-segment elevation or unstable angina.

Related Products

List of related products
FondaRed 7.5 Injection

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to fondaparinux or any other inactive ingredients present along with it.
Active major bleeding
This medicine is not recommended for use in patients having major active bleeding due to the increased risk of worsening of the patient’s condition.
Bacterial endocarditis
This medicine is not recommended for use in patients with bacterial endocarditis due to the increased risk of worsening of the patient’s condition.
Severe renal impairment
This medicine is not recommended for use in patients with severe renal impairment (creatinine clearance < 30 ml/min) due to the increased risk of worsening of the patient’s condition.

Warnings

Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings
Subcutaneous use only
This medicine is intended for subcutaneous use only. Do not administer intramuscularly.
Bleeding
This medicine is known to cause severe bleeding. It is not recommended for patients with conditions like gastrointestinal bleeding, head injury, and patients who are about to undergo surgery. Any symptoms of blood in the stools, vomiting blood, or blood in the urine should be reported to the doctor on priority. Close monitoring of prothrombin time is necessary while receiving this medicine.
Other medicines
Concomitant administration of this medicine and other anticoagulants may enhance the risk of bleeding. These agents include desirudin, fibrinolytic agents, GP IIb/IIIa receptor antagonists, heparin, heparinoids, or Low Molecular Weight Heparin (LMWH). Other antiplatelet medicinal products (acetylsalicylic acid, dipyridamole, sulfinpyrazone, ticlopidine or clopidogrel), and NSAIDs should be used with caution. Close monitoring is necessary if coadministered.
Spinal or epidural Anesthesia and Post-operative Indwelling Epidural catheter use
Use of this medicine with spinal or epidural anesthesia or spinal puncture may result in spinal or epidural hematomas, which may result in long-term or permanent paralysis. The risk of these events may be higher with post-operative use of indwelling epidural catheters or concomitant use of other drugs affecting hemostasis such as NSAIDs. Monitor patients undergoing these procedures for signs and symptoms of neurologic impairment such as midline back pain, sensory and motor deficits (numbness, tingling, or weakness in lower limbs), and bowel or bladder dysfunction. Consider the potential risks and benefits before neuraxial intervention in patients anticoagulated or who may be anticoagulated for thromboprophylaxis.
Low body weight
This medicine is not recommended for Deep vein thrombosis (DVT)- prophylaxis if the patients weigh below 50 kg due to the increased risk of bleeding.
Platelet Count
This medicine should be used with caution since it may deplete the platelet count and increase the risk of thrombocytopenia. Regular monitoring of the platelet count is necessary while receiving this medicine. It is advised to discontinue the therapy with this medicine if the platelet count falls below 100,000/mm3.
Use in Children
This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Dosage

Missed Dose
This medicine is usually administered in a clinical or hospital setup. However, if you are administering it at home and missed a scheduled dose, then call your doctor immediately for further instructions.
Overdose
Seek emergency medical attention in case of an overdose or suspected overdose. Symptoms of an overdose may include nosebleed, unusual bruising and bleeding, and the presence of blood in stool or urine.

General Instructions

Administer this medicine exactly as instructed by the doctor. It should not be injected into the muscles. It is advised to administer this medicine under the supervision of a doctor in a clinical setup with regular monitoring of blood clotting time and other related parameters. Your doctor may ask you to undergo certain tests to determine the safety of use of this medicine.